Lowering effect of an isoflavone-rich fermented soybean extract on the serum cholesterol concentrations in female rats, with or without ovariectomy, but not in male rats

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 7, 2006, Pages 1547-1556

  Kishida, Taro ^a   Mizushige, Takafumi ^a   Nagamoto, Manabu ^a   Ohtsu, Yohhei ^a   Izumi, Tohru ^b   Obata, Akio ^b   Ebihara, Kiyoshi ^a  

^a EHIME UNIVERSITY   (Japan)

^b KIKKOMAN CORPORATION   (Japan)

Author keywords

Estrogenic effect; LDL receptor; Rat; Sex specificity; Soybean isoflavone

Indexed keywords

CHOLESTEROL; FERMENTATION; GENES; GENETIC ENGINEERING; HORMONES; PROTEINS;

ESTROGENIC EFFECT; LDL RECEPTOR; RAT; SEX SPECIFICITY; SOYBEAN ISOFLAVONE;

FOOD PRODUCTS;

BILE ACID; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN RECEPTOR; PLANT EXTRACT;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DRUG EFFECT; EATING; FECES; FEMALE; FERMENTATION; GENE EXPRESSION; LIVER; MALE; METABOLISM; OVARIECTOMY; RAT; SEX DIFFERENCE; SOYBEAN; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BILE ACIDS AND SALTS; CHOLESTEROL; EATING; FECES; FEMALE; FERMENTATION; GENE EXPRESSION; ISOFLAVONES; LIVER; MALE; OVARIECTOMY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; SEX FACTORS; SOYBEANS;

GLYCINE MAX;

EID: 33746401877     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.50008     Document Type: Article

References (65)

1. Messina, M. J., Legumes and soybeans, overview of their nutritional profiles and health effects. Am. J. Clin. Nutr., 70, 439-450 (1999).
2. Kurzer, M. S., and Xu, X., Dietary phytoestrogens. Annu. Rev. Nutr., 17, 353-381 (1997).
3. Barnes, S., The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res. Treat., 46, 169-179 (1997).
4. Messina, M. J., and Loprinzi, C. L., Soy for breast cancer survivors, a critical review of the literature. J. Nutr., 131, 3095-3108 (2001).
5. Carroll, K. K., Review of clinical studies on cholesterol-lowering response to soy protein. J. Am. Diet Assoc., 91, 820-827 (1991).
6. Kritchevsky, D., Protein and atherosclerosis. J. Nutr. Sci. Vitaminol. (Tokyo), 36, S81-S86 (1990).
7. Sugano, M., and Koba, K., Dietary protein and lipid metabolism: a multifunctional effect. Ann. NY Acad. Sci., 676, 215-222 (1993).
8. Lichtenstein, A. H., Soy protein, isoflavones and cardiovascular disease risk. J. Nutr., 128, 1589-1592 (1998).
9. Anthony, M. S., Soy and cardiovascular disease: cholesterol lowering and beyond. J. Nutr., 130, 662-663 (2000).
10. Clarkson, T. B., Soy, soy phytoestrogens and cardiovascular disease. J. Nutr., 132, 566-569 (2002).
11. Potter, S. M., Baum, J. A., Teng, H., Stillman, R. J., Shay, N. F., and Erdman Jr., J. W., Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr., 68, 1375-1379 (1998).
12. Anthony, M. S., Clarkson, T. B., and Williams, J. K., Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am. J. Clin. Nutr., 68, 1390-1393 (1998).
13. Fukui, K., Tachibana, N., Wanezaki, S., Tsuzaki, S., Takamatsu, K., Yamamoto, T., Hashimoto, Y., and Shimoda, T., Isoflavone-free soy protein prepared by column chromatography reduces plasma cholesterol in rats. Agric. Food Chem., 50, 5717-5721 (2002).
14. Clarkson, T. B., Soy, soy phytoestrogens and cardiovascular disease. J. Nutr., 132, 566S-569S (2002).
15. Wangen, K. E., Duncan, A. M., Xu, X., and Kurzer, M. S., Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr., 73, 225-231 (2001).
16. Uesugi, T., Toda, T., Tsuji, K., and Ishida, H., Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol. Pharm. Bull., 24, 368-372 (2001).
17. Han, K. K., Soares Jr., J. M., Haidar, M. A., de Lima, G. R., and Baracat, E. C., Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet. Gynecol., 99, 389-394 (2002).
18. Balmir, F., Staack, R., Jeffrey, E., Jimenez, M. D., Wang, L., and Potter, S. M., An extract of soy flour influences serum cholesterol and thyroid hormones in rats and hamsters. J. Nutr., 126, 3046-3053 (1996).
19. Greaves, K. A., Parks, J. S., Williams, J. K., and Wagner, J. D., Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J. Nutr., 129, 1585-1592 (1999).
20. Blair, R. M., Appt., S. E., Bennetau-Pelissero, C., Clarkson, T. B., Anthony, M. S., Lamothe, V., and Potter, S. M., Dietary soy and soy isoflavones have gender-specific effects on plasma lipids and isoflavones in golden Syrian f(1)b hybrid hamsters. J. Nutr., 132, 3585-3591 (2002).
21. Lucas, E. A., Khalil, D. A., Daggy, B. P., and Arjmandi, B. H., Ethanol-extracted soy protein isolate does not modulate serum cholesterol in golden Syrian hamsters: a model of postmenopausal hypercholesterolemia. J. Nutr., 131, 211-214 (2001).
22. Anthony, M. S., Clarkson, T. B., and Williams, J. K., Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am. J. Clin. Nutr., 68, 1390-1393 (1998).
23. Anthony, M. S., Clarkson, T. B., Hughes Jr., C. L., Morgan, T. M., and Burke, G. L., Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr., 126, 43-50 (1996).
24. Hidaka, S., Okamoto, Y., Miyazaki, K., and Uesugi, T., Evaluation of a soybean product fujiflavone P40 as an antiosteoporotic agent in rats. Phytother. Res., 17, 112-119 (2003).
25. Nogowski, L., Mackowiak, P., Kandulska, K., Szkudelski, T., and Nowak, K. W., Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann. Nutr. Metab., 42, 360-366 (1998).
26. Borradaile, N. M., de Dreu, L. E., Wilcox, L. J., Edwards, J. Y., and Huff, M. W., Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem. J., 366, 531-539 (2002).
27. Folch, J., Lees, M., and Sloane Stanley, G. H., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497-509 (1957).
28. Kishida, T., Ishikawa, H., Tsukaoka, M., Ohga, H., Ogawa, H., and Ebihara, K., Increase of bile acids synthesis and excretion caused by taurine administration prevents the ovariectomy-induced increase in cholesterol concentrations in the serum low-density lipoprotein fraction of Wistar rats. J. Nutr. Biochem., 14, 7-16 (2003).
29. Eneroth, P., Hellstrom, K., and Sjovall, J., A method for quantitative determination of bile acids in human feces. Bile acids and steroids. Acta Chem. Scand., 22, 1729-1744 (1968).
30. Sheltawy, M. J., and Losowsky, M. S., Determination of faecal bile acids by an enzymic method. Clin. Chim. Acta, 64, 127-132 (1975).
31. Chomczynski, P., and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem., 162, 156-159 (1987).
32. Pfaffl, M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res., 29, 2002-2007 (2001).
33. Kishida, T., Nagamoto, M., Ohtsu, Y., Watakabe, M., Ohshima, D., Nashiki, K., Mizushige, T., Izumi, T., Obata, A., and Ebihara, K., Lack of an inducible effect of dietary soy isoflavones on the mRNA abundance of hepatic cytochrome P-450 isozymes in rats. Biosci. Biotechnol. Biochem., 68, 508-515 (2004).
34. Liepa, G. U., Masoro, E. J., Bertrand, H. A., and Yu, B. P., Food restriction as a modulator of age-related changes in serum lipids. Am. J. Physiol., 238, E253-E257 (1980).
35. Choi, Y. S., Goto, S., Ikeda, I., and Sugano, M., Age-related changes in lipid metabolism in rats: the consequence of moderate food restriction. Biochim. Biophys. Acta, 963, 237-242 (1988).
36. Lane, M. A., Tilmont, E. M., De Angelis, H., Handy, A., Ingram, D. K., Kemnitz, J. W., and Roth, G. S., Short-term calorie restriction improves disease-related markers in older male rhesus monkeys (Macaca mulatta). Mech. Ageing Dev., 112, 185-196 (2000).
37. Levin, S., Semler, D., and Ruben, Z., Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicol. Pathol., 21, 1-14 (1993).
38. Jenkins, D. J., Kendall, C. W., Jackson, C. J., Connelly, P. W., Parker, T., Faulkner, D., Vidgen, E., Cunnane, S. C., Leiter, L. A., and Josse, R. G., Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr., 76, 365-372 (2002).
39. Potter, S. M., Bakhit, R. M., Essex-Sorlie, D. L., Weingartner, K. E., Chapman, K. M., Nelson, R. A., Prabhudesai, M., Savage, W. D., Nelson, A. I., Winter, L. W., and Erdman Jr., J. W., Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am. J. Clin. Nutr., 58, 501-506 (1993).
40. Peluso, M. R., Winters, T. A., Shanahan, M. F., and Banz, W. J., A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J. Nutr., 130, 2333-2342 (2000).
41. Lundeen, S. G., Carver, J. M., McKean, M. L., and Winneker, R. C., Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels. Endocrinology, 138, 1552-1558 (1997).
42. Abbey, M., Owen, A., Suzakawa, M., Roach, P., and Nestel, P. J., Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas, 33, 259-269 (1999).
43. Blay, M., Peinado-Onsurbe, J., Grasa, M. M., Diaz-Silva, M., Fernandez-Lopez, J. A., Remesar, X., and Alemany, M., Effect of oral oleoyl-estrone treatment on plasma lipoproteins and tissue lipase activities of Zucker lean and obese female rats. Int. J. Obes. Relat. Metab. Disord., 26, 618-626 (2002).
44. Rosa Brito-Zurita, O., Posadas-Romero, C., Hermosillo, A. G., Zamora-Gonzalez, J., Hernandez-Ono, A., Cardoso-Saldana, G., and Torres-Tamayo, M., Estrogen effect on heart rate variability in hypertensive postmenopausal women. Maturitas, 44, 39-48 (2003).
45. Lewis-Barned, N. J., Sutherland, W. H., Walker, R. J., Walker, H. L., De Jong, S. A., Edwards, E. A., and Markham, V. H., Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women. J. Clin. Endocrinol. Metab., 84, 3534-3538 (1999).
46. Cassidy, A., Bingham, S., and Setchell, K., Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br. J. Nutr., 74, 587-601 (1995).
47. Miksicek, R. J., Estrogenic flavonoids: structural requirements for biological activity. Proc. Soc. Exp. Biol. Med., 208, 44-50 (1995).
48. Parini, P., Angelin, B., Stavreus-Evers, A., Freyschuss, B., Eriksson, H., and Rudling, M., Biphasic effects of the natural estrogen 17beta-estradiol on hepatic cholesterol metabolism in intact female rats. Arterioscler. Thromb. Vasc. Biol., 20, 1817-1823 (2000).
49. Parini, P., Angelin, B., and Rudling, M., Importance of estrogen receptors in hepatic LDL receptor regulation. Arterioscler. Thromb. Vasc. Biol., 17, 1800-1805 (1997).
50. Diel, P., Tissue-specific estrogenic response and molecular mechanisms. Toxicol. Lett., 127, 217-224 (2002).
51. Rollerova, E., and Urbancikova, M., Intracellular estrogen receptors, their characterization and function (review). Endocr. Regul., 34, 203-218 (2000).
52. Abbey, M., Owen, A., Suzakawa, M., Roach, P., and Nestel, P. J., Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas, 33, 259-269 (1999).
53. Di Croce, L., Bruscalupi, G., and Trentalance, A., Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment. Biochem. Biophys. Res. Commun., 224, 345-350 (1996).
54. Kirk, E. A., Sutherland, P., Wang, S. A., Chait, A., and LeBoeuf, R. C., Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J. Nutr., 128, 954-959 (1998).
55. Lee, R. G., Shah, R., Sawyer, J. K., Hamilton, R. L., Parks, J. S., and Rudel, L. L., ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice. J. Lipid Res., 46, 1205-1212 (2005).
56. Lee, R. G., Willingham, M. C., Davis, M. A., Skinner, K. A., and Rudel, L. L., Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J. Lipid Res., 41, 1991-2001 (2000).
57. Gregg, R. E., and Wetterau, J. R., The molecular basis of abetalipoproteinemia. Curr. Opin. Lipidol., 5, 81-86 (1994).
58. Cianflone, K. M., Yasruel, Z., Rodriguez, M. A., Vas, D., and Sniderman, A. D., Regulation of Apo B secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J. Lipid Res., 31, 2045-2055 (1990).
59. Tanaka, M., Jingami, H., Otani, H., Cho, M., Ueda, Y., Arai, H., Nagano, Y., Doi, T., Yokode, M., and Kita, T., Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes. J. Biol. Chem., 268, 12713-12718 (1993).
60. Van Lenten, B. J., Melchior, G. W., and Roheim, P. S., Lipoprotein metabolism in the ovariectomized rat. J. Lipid Res., 24, 1475-1484 (1983).
61. Clarkson, T. B., Adams, M. R., Kaplan, J. R., and Koritnik, D. R., Psychosocial and reproductive influences on plasma lipids, lipoproteins, and atherosclerosis in nonhuman primates. J. Lipid Res., 25, 1629-1634 (1984).
62. Mullen, E., Brown, R. M., Osborne, T. F., and Shay, N. F., Soy isoflavones affect sterol regulatory element binding proteins (SREBPs) and SREBP-regulated genes in HepG2 cells. J. Nutr., 134, 2942-2947 (2004).
63. Jenkins, D. J., Kendall, C. W., Jackson, C. J., Connelly, P. W., Parker, T., Faulkner, D., Vidgen, E., Cunnane, S. C., Leiter, L. A., and Josse, R. G., Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr., 76, 365-372 (2002).
64. Potter, S. M., Bakhit, R. M., Essex-Sorlie, D. L., Weingartner, K. E., Chapman, K. M., Nelson, R. A., Prabhudesai, M., Savage, W. D., Nelson, A. I., Winter, L. W., and Erdman Jr., J. W., Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am. J. Clin. Nutr., 58, 501-506 (1993).
65. Peluso, M. R., Winters, T. A., Shanahan, M. F., and Banz, W. J., A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. J. Nutr., 130, 2333-2342 (2000).